Vanda Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of a portfolio of clinical-stage, small molecule product candidates for central nervous system disorders.

Quarterly Report (Form 10-Q | Period ending 2024-09-30)

Current Report (Form 8-K | Period ending 2024-11-06)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Vanda Pharmaceuticals (VNDA US)

Quarterly Report (Form 10-Q | Period ending 2024-09-30)

Current Report (Form 8-K | Period ending 2024-11-06)

Current Report (Form 8-K | Period ending 2024-10-14)

Current Report (Form 8-K | Period ending 2024-10-02)

Current Report (Form 8-K | Period ending 2024-09-19)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)